Back to search

Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.

Data up to Jan 2025

Published1992
Citations87
References24

Total Citations Per Year

Abstract

References (24)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Beyond Cholesterol

1989 • 6,533 citations

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

1984 • 1,631 citations

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

1987 • 1,051 citations

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

1990 • 836 citations

Role of vitamin E in preventing the oxidation of low-density lipoprotein

1991 • 649 citations

Probucol inhibits oxidative modification of low density lipoprotein.

1986 • 633 citations

Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans

1991 • 323 citations

Safety of oral intake of vitamin E

1988 • 298 citations

Comparison of the efficiencies of several natural and synthetic antioxidants in aqueous SDS [sodium dodecyl sulfate] micelle solutions

1988 • 241 citations

Plasma Vitamins E and A Inversely Correlated to Mortality from Ischemic Heart Disease in Cross‐Cultural Epidemiology

1989 • 240 citations

Effects of probucol on xanthomata regression in familial hypercholesterolemia

1986 • 232 citations

Probucol

1989 • 161 citations

Probucol attenuates the development of aortic atherosclerosis in cholesterol‐fed rabbits

1989 • 142 citations

Vitamin E and other Lipophilic Antioxidants Protect LDL against Oxidation

1989 • 134 citations

Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.

1989 • 107 citations

Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B.

1986 • 92 citations

The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.

1983 • 78 citations

Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.

1991 • 73 citations

Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro

1990 • 62 citations

Prevention of atherosclerotic progression in Watanabe rabbits by probucol

1988 • 57 citations

Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay.

1988 • 39 citations

Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol

1988 • 32 citations

Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits.

1989 • 24 citations

Cited By (0)

Loading...